BDBM243205 (s)-n-(1-(3-chlorophenyl)-2-hydroxyethyl)-5,5-dimethyl-2-((tetrahydro-2h-pyran-4-yl)amino)-5h-pyrrolo[3,4-d]pyrimidine-6(7h)-carboxamide::US9546173, cmpd 2
SMILES: CC1(C)N(Cc2nc(NC3CCOCC3)ncc12)C(=O)N[C@H](CO)c1cccc(Cl)c1
InChI Key: InChIKey=OYZABGBXJPBVCZ-LJQANCHMSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mitogen-activated protein kinase 1 (Homo sapiens (Human)) | BDBM243205 ((s)-n-(1-(3-chlorophenyl)-2-hydroxyethyl)-5,5-dime...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Novartis AG US Patent | Assay Description Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept... | US Patent US9546173 (2017) BindingDB Entry DOI: 10.7270/Q2GT5Q52 | |||||||||||
More data for this Ligand-Target Pair |